Respiratory Allergy Profile Region XVIII: Alaska
Also known as: ImmunoCAP®
Use
This test is a regional environmental respiratory allergy panel tailored to the State of Alaska (Region XVIII), designed to detect allergen‑specific IgE antibodies (and total IgE) that indicate sensitization to common local respiratory allergens among patients presenting with suspected allergic respiratory disease such as allergic rhinitis or asthma (per Quest’s regional respiratory profiles using ImmunoCAP IgE testing) ([device.report](https://device.report/m/9a499fc38d34e36c42c86d4ebcfad1a8456a8ffa2cb381b3246feef29e9bc49c_pdf?utm_source=openai)).
Special Instructions
Uses the ImmunoCAP Specific IgE blood test via fluoroenzyme immunoassay methodology. Submission requirements include 5 mL preferred or 2.5 mL minimum serum in a plastic vial ([device.report](https://device.report/m/9a499fc38d34e36c42c86d4ebcfad1a8456a8ffa2cb381b3246feef29e9bc49c_pdf?utm_source=openai)).
Limitations
Not provided in the source.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL preferred or 2.5 mL minimum
Minimum Volume
Not provided
Container
plastic vial